Samsung Biologics inks 2 new deals worth $668 mn with European pharma
Seoul, Nov 20 (SocialNews.XYZ) Samsung Biologics said on Wednesday it has won two new contract manufacturing deals with a combined value of 930.4 billion won ($667.7 million) from a Europe-based biopharmaceutical firm. The deals, set…